Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutraceutix

This article was originally published in The Tan Sheet

Executive Summary

Ingredient supplier reports year-end estimated net earnings of $200,000 compared to $584,217 loss in 1999, although sales dipped 13.6% to $8.9 mil. Fourth quarter sales increased 7% to $2.7 mil.; earnings of approximately $100,000 recorded compared to $550,626 loss in 4Q 1999. Redmond, Wash.-based company cites second quarter cost reductions and gross margin strengthening for bottom line improvement. Calcium D-glucarate sales of $1.2 mil. in 2000 represent a 6.2% increase. Firm also announces introduction of Low Osmolality sports drink and Controlled Delivery Technology Ma huang ingredient available in six- and 12-hour release profiles

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS092229

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel